Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 2
Submit an article Journal homepage
192
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Membranous glomerulonephritis as a novel paraneoplastic syndrome in a young man with chronic myeloid leukemia

Cécile TeumaDepartment of Nephrology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France
,
Solenne PelletierDepartment of Nephrology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France
,
Francine ToussaintDepartment of Paediatric Haemato-oncology, Bristol Royal Hospital for Children, University Hospitals Bristol, Bristol, UK
,
Maud RabeyrinPathology department, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France
,
Franck E. NicoliniHematology department 1G, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Bénite & INSERM U1052, CRCL, Lyon, France
,
Denis FouqueDepartment of Nephrology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France;Department of Paediatric Haemato-oncology, Bristol Royal Hospital for Children, University Hospitals Bristol, Bristol, UK;Pathology department, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France;Hematology department 1G, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Bénite & INSERM U1052, CRCL, Lyon, France;Carmen, Cens, Université de Lyon, Lyon, France
&
Frederic BaleydierPaediatric Haematology, Institut Hematologie et Oncologie Pediatrique, Hospices Civils de Lyon, Groupement Hospitalier Est, FranceCorrespondence[email protected]
 show all
Pages 483-485 | Received 02 Dec 2014, Accepted 02 Jun 2015, Published online: 18 Jul 2015

References

  • Lefaucheur C, Stengel B, Nochy D, et al. Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. Kidney Int 2006;70:1510–1517.
  • Bacchetta J, Juillard L, Cochat P, et al. Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol Hematol 2009;70:39–58.
  • Millot F, Baruchel A, Guilhot J, et al. Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial. J Clin Oncol 2011;29:2827–2832.
  • Baccarani M, Deininger MW, Rosti G, et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood 2013;122:872–884.
  • Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res 2006;118:397–407.
  • den Deurwaarder ES, Desar IM, Steenbergen EJ, et al. Kidney injury during VEGF inhibitor therapy. Neth J Med 2012;70:267–271.
  • Kaspers GJ, Zimmermann M, Reinhardt D, et al. Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group. J Clin Oncol 2013;31:599–607.
  • Glassock RJ. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am J Kidney Dis 2010;56:157–167.
  • Thariat J, Vendrely B, Roca S, et al. [Renal involvement in cancer and renal paraneoplastic syndromes]. Bull Cancer 2012;99:263–75.
  • Haas M, VanBeek C. Glomerular diseases associated with hematopoietic neoplasms: an expanding spectrum. Kidney Int 2011; 80:701–703.
  • Said SM, Leung N, Sethi S, et al. Myeloproliferative neoplasms cause glomerulopathy. Kidney Int 2011;80:753–759.
  • Talwar R, Dash SC, Kucheria K. A case of chronic myeloid leukemia complicated with minimal change nephrotic syndrome. Acta Haematol 2003;109:101–103.
  • Subramanian M, Kilara N, Manjunath R, et al. Membrano-proliferative glomerulonephritis secondary to chronic myeloid leukemia. Saudi J Kidney Dis Transpl 2010;21:738–41.
  • de Faria JB, Alves MA, Pedrini H, et al. [Nephrotic syndrome caused by membranous glomerulonephritis associated with chronic myeloid leukemia]. AMB Rev Assoc Med Bras 1991;37:47–49.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.